Vimarsana
Biggest News Aggregation in the World

Joe Edelman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joe Edelman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joe Edelman Today - Breaking & Trending Today

BLOOMBERG Bloomberg Surveillance February 25, 2016 - Vimarsana News

BLOOMBERG Bloomberg Surveillance February 25, 2016

Were worrying about commodities. They both disappointed with huge losses. Tom correlated fragilitys across all markets. Nothing dramatic other than the china news. You follow on 48 hours or so. It is heads up. We have a great set of guests to drive the market discussion. Francine you are right. Lets get bloombergs first word news with caroline hyde. Caroline austria is not waiting for the European Union to come up with a response to the refugee crisis. Wayshave agreed on several to cut off the flow of refugees. Y would essentially limit bar people from countries economist are warning the u. K....

CNBC Fast Money Halftime Report May 5, 2016 - Vimarsana News

CNBC Fast Money Halftime Report May 5, 2016

And now, with the production schedule, ceo elon musk is responding to the naysayers and saying on the conference call, what i find ironic for the naysayers they transition from saying it is impossible to saying it is obvious. I say, wait a second is it obvious or impossible, because it cant be both. Who is right, chanos or musk, pete . Well, in the short term or the longer teerm term, it is chanos, and the reason i is a they is because they have had nothing but production issues for quite some time now, and the delays and the issues and now talking about ramping up, and going from 50,000 to 90...

Without Human Values, What Stops AI From Acting As A Sociopath? - Vimarsana News

Without Human Values, What Stops AI From Acting As A Sociopath?

Human values need to be integrated into Large Language Models. Can this be done democratically?

Source: forbes.com
This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now - Vimarsana News

This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients.

Source: forbes.com
Is Cytokinetics (CYTK) a Good Long-Term Investment? - Vimarsana News

Is Cytokinetics (CYTK) a Good Long-Term Investment?

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.